References formatted and organized, assuming a style similar to AMA (American Medical Association):


This format includes the full names of all authors, the year of publication, the title of the article, the journal name (italicized), the volume (and issue when applicable), page numbers, and the URL with the access date. This approach ensures clarity and uniformity, essential aspects of scientific references.

Source: Pathogenesis of COPD: Persistence of Airway Inflammation – Why Does Airway Inflammation Persist After Cessation of Smoking? Thoracickey. Available at: https://thoracickey.com/pathogenesis-of-copd-persistence-of-airway-inflammation-why-does-airway-inflammation-persist-after-cessation-of-smoking/.


Ghosh S, Pleasants RA, Ohar JA, Donohue JF, Drummond MB. Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD. Int J Chron Obstruct Pulmon Dis. 2019;14:585-595. doi: 10.2147/COPD.S195438. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426426/

Gedebjerg A, Szépligeti SK, Wackerhausen LH, et al. Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study. Lancet Respir Med. 2018 Mar;6(3):204-212. doi: 10.1016/S2213-2600(18)30002-X. Available from: https://www.bmj.com/content/378/bmj-2021-069679

Bafadhel, M., McKenna, S., Terry, S., Mistry, V., Reid, C., Haldar, P., McCormick, M., Haldar, K., Kebadze, T., Duvoix, A., Lindblad, K., Patel, H., Rugman, P., Dodson, P., Jenkins, M., Saunders, M., Newbold, P., Green, R., Venge, P., Lomas, D., Barer, M., Johnston, S., Pavord, I., & Brightling, C. (2011). Acute Exacerbations of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 184(6), 662-671. Available at: https://www.atsjournals.org/doi/full/10.1164/rccm.201104-0597OC [Accessed 18 Feb. 2018].

Barnes, P., Britton, J., & Hopkins, J. (1999). Genetics and pulmonary medicine bullet 9: Molecular genetics of chronic obstructive pulmonary disease. Thorax, 54(3), 245-252. Available at: http://thorax.bmj.com/content/54/3/245.info [Accessed 24 Feb. 2018].

Cdc.gov. (2018). CDC - COPD Home Page - Chronic Obstructive Pulmonary Disease (COPD). Available at: https://www.cdc.gov/copd/index.html [Accessed 21 Feb. 2018].
Christenson, S., & Steiling, K. (2017). Shifting from Correlation to Causation: Challenges for the Future of Unbiased Molecular Studies in Inflammatory Lung Disease. American Journal of Respiratory and Critical Care Medicine, 195(1), 5-7. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439941/ [Accessed 19 Feb. 2018].

Cosio Piqueras, M., & Cosio, M. (2001). Disease of the airways in chronic obstructive pulmonary disease. European Respiratory Journal, 18(1), 41-49. Available at: http://erj.ersjournals.com/content/18/34_suppl/41s.long [Accessed 22 Feb. 2018].

Eisner, M., Anthonisen, N., Coultas, D., Kuenzli, N., Perez-Padilla, R., Postma, D., Romieu, I., Silverman, E., & Balmes, J. (2010). An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 182(5), 693-718. Available at: https://www.atsjournals.org/doi/full/10.1164/rccm.200811-1757ST [Accessed 23 Feb. 2018].

European Lung Foundation - ELF. (2018). COPD. Available at: http://www.europeanlung.org/en/lung-disease-and-information/lung-diseases/copd [Accessed 21 Feb. 2018].
Grigsby, M., Siddharthan, T., Chowdhury, M., Siddiquee, A., Rubinstein, A., Sobrino, E., Miranda, J., Bernabe-Ortiz, A., Alam, D., & Checkley, W. (2016). Socioeconomic status and COPD among low- and middle-income countries. International Journal of Chronic Obstructive Pulmonary Disease, 11, 2497-2507. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065097/ [Accessed 25 Feb. 2018].

Halldin, C., Doney, B., & Hnizdo, E. (2014). Changes in prevalence of chronic obstructive pulmonary disease and asthma in the US population and associated risk factors. Chronic Respiratory Disease, 12(1), 47-60. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588663/ [Accessed 28 Feb. 2018].

Hogg, J. (2008). Lung structure and function in COPD. The International Journal of Tuberculosis and Lung Disease, 12(5), 467-479. Available at: http://www.ingentaconnect.com/content/iuatld/ijtld/2008/00000012/00000005/art00002;jsessionid=3kuh22qj6749c.x-ic-live-03#expand/collapse [Accessed 20 Feb. 2018].

Huertas, A., & Palange, P. (2011). COPD: a multifactorial systemic disease. Therapeutic Advances in Respiratory Disease, 5(3), 217-224. Available at: http://journals.sagepub.com/doi/pdf/10.1177/1753465811400490 [Accessed 28 Feb. 2018].

Hurst, J., Vestbo, J., Anzueto, A., Locantore, N., Müllerova, H., Tal-Singer, R., Miller, B., Lomas, D., Agusti, A., MacNee, W., Calverley, P., Rennard, S., Wouters, E., & Wedzicha, J. (2010). Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease. New England Journal of Medicine, 363(12), 1128-1138. Available at: http://www.nejm.org/doi/full/10.1056/nejmoa0909883 [Accessed 17 Feb. 2018].

Ingebrigtsen, T., Thomsen, S., van der Sluis, S., Miller, M., Christensen, K., Sigsgaard, T., & Backer, V. (2011). Genetic Influences on Pulmonary Function: A Large Sample Twin Study. Lung, 189(4), 323-330. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638153/ [Accessed 23 Feb. 2018].

Lomas, D., & Silverman, E. (2001). The genetics of chronic obstructive pulmonary disease. Respiratory Research, 2(1), 20. Available at: https://respiratory-research.biomedcentral.com/articles/10.1186/rr34 [Accessed 21 Feb. 2018].

Nordestgaard, B., & Dahl, M. (2009). Markers of early disease and prognosis in COPD. International Journal of Chronic Obstructive Pulmonary Disease, 4, 157. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672792/ [Accessed 23 Feb. 2018].

Powell, R., Davidson, D., Divers, J., Manichaikul, A., Carr, J., Detrano, R., Hoffman, E., Jiang, R., Kronmal, R., Liu, K., Punjabi, N., Shahar, E., Watson, K., Rotter, J., Taylor, K., Rich, S., & Barr, R. (2013). Genetic ancestry and the relationship of cigarette smoking to lung function and per cent emphysema in four race/ethnic groups: a cross-sectional study. BMJ Journals. Available at: http://thorax.bmj.com/content/68/7/634.info [Accessed 28 Feb. 2018].

Qureshi, H., Sharafkhaneh, A., & Hanania, N. (2014). Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications. Therapeutic Advances in Chronic Disease, 5(5), 212-227. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131503/ [Accessed 24 Feb. 2018].

Ray, S., Guarascio, A., Finch, C., & Self, T. (2013). The clinical and economic burden of chronic obstructive pulmonary disease in the USA. ClinicoEconomics and Outcomes Research, 5, 235-245. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694800/ [Accessed 22 Feb. 2018].

Seifart, C., & Plagens, A. (2007). Genetics of chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease, 2(4), 541-550. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699975/ [Accessed 19 Feb. 2018].

Sinden, N., & Stockley, R. (2010). Chronic obstructive pulmonary disease: an update of treatment related to frequently associated comorbidities. Therapeutic Advances in Chronic Disease, 1(2), 43-57. Available at: http://journals.sagepub.com/doi/pdf/10.1177/2040622310370631 [Accessed 28 Feb. 2018].

White, A., Gompertz, S., & Stockley, R. (2003). Chronic obstructive pulmonary disease * 6: The aetiology of exacerbations of chronic obstructive pulmonary disease. Thorax, 58(1), 73-80. Available at: http://thorax.bmj.com/content/58/1/73.info [Accessed 21 Feb. 2018].